Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
    • Legit.Health Plus TF index
    • Legit.Health Plus STED
    • Legit.Health Plus description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 🗄 Drafts
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_BI_2024
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_PH_2022.
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_PH_2024_NIPPLE
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_SAN_2024
        • R-TF-015-004 Clinical investigation plan LEGIT_COVIDX_EVCDAO_2022
        • R-TF-015-004 Clinical investigation plan LEGIT_MC_EVCDAO_2019
        • R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.
        • R-TF-015-004 Clinical investigation plan Legit.Health_IDEI_2023.
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_BI_2024
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_DAO_Derivación_O_2022
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_DAO_Derivación_PH_2022
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_PH_2024
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_PH_2024_NIPPLE
        • R-TF-015-006 Clinical investigation report LEGIT.HEALTH_SAN_2024
        • R-TF-015-006 Clinical investigation report LEGIT_COVIDX_EVCDAO_2022
        • R-TF-015-006 Clinical investigation report LEGIT_MC_EVCDAO_2019
        • R-TF-015-006 Clinical investigation report Legit.Health_IDEI_2023
      • R-TF-015-008 Clinical development plan_2023_002
    • Design and development
    • Design History File (DHF)
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
  • Licenses and accreditations
  • External documentation
  • Procedures
  • Records
  • TF_Legit.Health_Plus
  • Clinical
  • Investigation

Investigation

🗃️ 🗄 Drafts

4 items

📄️ R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_BI_2024

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_PH_2022.

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_PH_2024_NIPPLE

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_SAN_2024

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT_COVIDX_EVCDAO_2022

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT_MC_EVCDAO_2019

Scope

📄️ R-TF-015-004 Clinical investigation plan LEGIT.HEALTH_DAO_Derivación_O_2022.

📄️ R-TF-015-004 Clinical investigation plan Legit.Health_IDEI_2023.

Scope

📄️ R-TF-015-006 Clinical investigation report LEGIT.HEALTH_BI_2024

Jump to Clinical Performance, Efficacy, and Safety.

📄️ R-TF-015-006 Clinical investigation report LEGIT.HEALTH_DAO_Derivación_O_2022

Research Title

📄️ R-TF-015-006 Clinical investigation report LEGIT.HEALTH_DAO_Derivación_PH_2022

Research Title

📄️ R-TF-015-006 Clinical investigation report LEGIT.HEALTH_PH_2024

Product Identification

📄️ R-TF-015-006 Clinical investigation report LEGIT.HEALTH_PH_2024_NIPPLE

Jump to Clinical Performance, Efficacy, and Safety.

📄️ R-TF-015-006 Clinical investigation report LEGIT.HEALTH_SAN_2024

Jump to Clinical Performance, Efficacy, and Safety.

📄️ R-TF-015-006 Clinical investigation report LEGIT_COVIDX_EVCDAO_2022

Jump to Clinical Performance, Efficacy, and Safety.

📄️ R-TF-015-006 Clinical investigation report LEGIT_MC_EVCDAO_2019

Jump to Clinical Performance, Efficacy, and Safety.

📄️ R-TF-015-006 Clinical investigation report Legit.Health_IDEI_2023

Jump to Clinical Performance, Efficacy, and Safety.

Previous
R-TF-015-007 Delaration of interest Clinical evaluation team 2023_006
Next
🗄 Drafts
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)